News
PLB-002, PrimeLink Bio’s Anti-Claudin 6 ADC, Receives IND Acceptance from NMPA and FDA

PLB-002, PrimeLink Bio’s Anti-Claudin 6 ADC, Receives IND Acceptance from NMPA and FDA

18 Sep,2025

MORE
Breaking: PrimeLink Bio Named 2025 Shenzhen Seed Unicorn

Breaking: PrimeLink Bio Named 2025 Shenzhen Seed Unicorn

17 Sep,2025

MORE
PrimeLink to Present Preclinical Data of Two ADC Programs at AACR 2025

PrimeLink to Present Preclinical Data of Two ADC Programs at AACR 2025

09 Apr,2025

MORE
「普灵生物」完成数亿元人民币融资，致力于打造自主知识产权的ADC技术平台，开发新一代ADC

「普灵生物」完成数亿元人民币融资，致力于打造自主知识产权的ADC技术平台，开发新一代ADC

01 Dec,2022

MORE
动脉新医药专访普灵生物两位创始人

动脉新医药专访普灵生物两位创始人

01 Dec,2022

MORE
< 1 >
免费热线

Tel:

0086 512-62652000

免费热线

E-mail:

hr@primelinkbio.com

地址

Add:

Building 4, Suhua Science Park , No.208 Tongyuan Road, Suzhou Industrial Park

Follow Us

©2022 PrimeLink BioTherapeutics  Powered by：CEglobal